Related Experiment Video
Updated: May 15, 2026

Detection of Post-Replicative Gaps Accumulation and Repair in Human Cells Using the DNA Fiber Assay
Published on: February 3, 2022
Synthetic lethality and cancer: cohesin and PARP at the replication fork
Nigel J O'Neil1, Derek M van Pel, Philip Hieter
1Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.
Abstract:
Cohesins are mutated in a significant number of tumors of various types making them attractive targets for chemotherapeutic intervention. However, cohesins have a spectrum of cellular roles including sister chromatid cohesion, transcription, replication, and repair. Which of these roles are central to cancer biology and which roles can be exploited for therapeutic intervention? Genetic interaction networks in yeast have identified synthetic lethal interactions between mutations in cohesin and replication fork mediators. These interactions are conserved in worms and in human cells suggesting that inhibition of replication fork stability mediators such as poly (ADP-ribose) polymerase (PARP) could result in the specific killing of tumors with cohesin mutations. These findings also highlight the utility of genetic interaction networks in model organisms for the identification of clinically relevant interactions. Here, we review this type of approach, emphasizing the power of synthetic lethal interactions to reveal new avenues for developing cancer therapeutics.
Insights
Cohesin mutations in cancer can be targeted by inhibiting replication fork stability. Synthetic lethal interactions reveal that targeting poly (ADP-ribose) polymerase (PARP) selectively kills cohesin-mutated tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cohesins play crucial roles in DNA replication, repair, and transcription.
- Cohesin mutations are prevalent in various cancer types, presenting therapeutic opportunities.
- Understanding cohesin's diverse functions is key to developing targeted cancer therapies.
Purpose of the Study:
- To explore the therapeutic potential of targeting cohesin-mutated cancers.
- To investigate the utility of genetic interaction networks in identifying cancer vulnerabilities.
- To highlight synthetic lethal interactions for novel therapeutic strategies.
Main Methods:
- Analysis of genetic interaction networks in model organisms (yeast, worms).
- Identification of conserved synthetic lethal interactions between cohesin and replication fork mediators.
- Review of therapeutic implications for targeting cohesin-mutated tumors.
Main Results:
- Synthetic lethal interactions between cohesin mutations and replication fork mediators are conserved across species.
- Inhibition of replication fork stability mediators, such as poly (ADP-ribose) polymerase (PARP), shows potential for selective killing of cohesin-mutated tumors.
- Genetic interaction networks are powerful tools for discovering clinically relevant vulnerabilities.
Conclusions:
- Targeting replication fork stability offers a promising therapeutic strategy for cohesin-mutated cancers.
- Synthetic lethality provides a framework for developing targeted cancer treatments.
- Model organism genetic screens are invaluable for translating basic research into clinical applications.
Related Concept Videos
Restarting Stalled Replication Forks
The DNA Replication Fork
The DNA Replication Fork
Homologous Recombination
Homologous Recombination
DNA Damage can Stall the Cell Cycle
